These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15672781)

  • 1. Chronic systemic inflammation in dialysis patients: an update on causes and consequences.
    Yao Q; Axelsson J; Stenvinkel P; Lindholm B
    ASAIO J; 2004; 50(6):lii-lvii. PubMed ID: 15672781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences.
    Yao Q; Axelsson J; Heimburger O; Stenvinkel P; Lindholm B
    Minerva Urol Nefrol; 2004 Sep; 56(3):237-48. PubMed ID: 15467502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation in end-stage renal failure: could it be treated?
    Stenvinkel P
    Nephrol Dial Transplant; 2002; 17 Suppl 8():33-8; discussion 40. PubMed ID: 12147775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation in end-stage renal disease: sources, consequences, and therapy.
    Stenvinkel P; Alvestrand A
    Semin Dial; 2002; 15(5):329-37. PubMed ID: 12358637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients.
    Yao Q; Lindholm B; Stenvinkel P
    Hemodial Int; 2004 Apr; 8(2):118-29. PubMed ID: 19379407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
    Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
    Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic inflammation and cardiovascular risk in hemodialysis].
    Pertosa G; Simone S; Soccio M; Marrone D; Grandaliano G
    G Ital Nefrol; 2003; 20(6):631-40. PubMed ID: 14732917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory and atherosclerotic interactions in the depleted uremic patient.
    Stenvinkel P
    Blood Purif; 2001; 19(1):53-61. PubMed ID: 11114578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-Stage Renal Disease, Inflammation and Cardiovascular Outcomes.
    Dai L; Golembiewska E; Lindholm B; Stenvinkel P
    Contrib Nephrol; 2017; 191():32-43. PubMed ID: 28910789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malnutrition -- inflammation -- atherosclerosis (MIA syndrome) in patients with renal failure].
    Pawlaczyk K; Oko A; Lindholm B; Czekalski S
    Pol Merkur Lekarski; 2003 Oct; 15(88):334-41; discussion 341-3. PubMed ID: 14974361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and nutrition in renal insufficiency.
    Kalantar-Zadeh K; Stenvinkel P; Pillon L; Kopple JD
    Adv Ren Replace Ther; 2003 Jul; 10(3):155-69. PubMed ID: 14708070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of vascular disease in renal failure.
    Ikizler TA
    Blood Purif; 2002; 20(1):6-10. PubMed ID: 11803153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Why do patients with kidney diseases end up with a heart of stone? Disturbances in calcium-phosphate balance and chronic inflammation important causes].
    Martola L; Elinder CG; Stenvinkel P
    Lakartidningen; 2003 Dec; 100(50):4180-3. PubMed ID: 14717005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of chronic inflammation in peritoneal dialysis.
    Wang AY
    Semin Nephrol; 2011 Mar; 31(2):159-71. PubMed ID: 21439430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malnutrition, inflammation and atherosclerosis (MIA-syndrome) in dialysis patients].
    de Mutsert R; Krediet RT
    Ned Tijdschr Geneeskd; 2006 Sep; 150(37):2023-7. PubMed ID: 17058458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation, malnutrition and atherosclerosis in end-stage renal disease: a global perspective.
    Nascimento MM; Pecoits-Filho R; Lindholm B; Riella MC; Stenvinkel P
    Blood Purif; 2002; 20(5):454-8. PubMed ID: 12207091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
    Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
    J Am Soc Nephrol; 2003 Jun; 14(6):1614-22. PubMed ID: 12761263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome -- the heart of the matter.
    Pecoits-Filho R; Lindholm B; Stenvinkel P
    Nephrol Dial Transplant; 2002; 17 Suppl 11():28-31. PubMed ID: 12386254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictors of mortality in dialysis patients--association between malnutrition, inflammation and atherosclerosis (MIA syndrome)].
    Perunicić-Peković G; Rasić-Milutinović Z; Pljesa S
    Med Pregl; 2004; 57(3-4):149-52. PubMed ID: 15462598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From MIA to FIFA: The vicious matrix of frailty, inflammation, fluid overload and atherosclerosis in peritoneal dialysis.
    Chan GC; Fung WW; Szeto CC; Ng JK
    Nephrology (Carlton); 2023 Apr; 28(4):215-226. PubMed ID: 36807408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.